Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Pluristem Therapeutics, Inc. (PSTI)

« Back to company index

PSTI Chatter Timeline

Stock Ticker for PSTI

Most Active Tweeters for PSTI

UserTweets
@GantosJ 8
@dakotafinancial 3
@macondailynews 2
@StunningFeline 2
@phatoftheland10 1

Recent Tweets for PSTI

outsider_alerts @outsider_alerts
$PSTI - PRICE x VOLUME ALERT - Price: 3.96, up 10.0% over prior 10 minute average, Volume: off the dang charts
October 21st 2019, 3:10pm
StunningFeline @StunningFeline
RT @GantosJ: With lack of suitable non-surgical therapeutic options for the growing population of CLI patients $PSTI cell-therapy demonstra…
October 21st 2019, 3:10pm
greyzone513 @greyzone513
RT @GantosJ: The $PSTI Cell-Therapy saved this #CLI 77 years old patient's leg from certain imputation as gangrene spread due #diabetes & 1…
October 21st 2019, 3:10pm
TimeWipe @TimeWipe
Possible breakout on $PSTI
October 21st 2019, 2:10pm
SwingTradeBot @SwingTradeBot
Rose Above 50 DMA today: $PSTI ... https://t.co/qwiJH6vr1O
October 21st 2019, 1:10pm
GantosJ @GantosJ
With lack of suitable non-surgical therapeutic options for the growing population of CLI patients $PSTI cell-therap… https://t.co/9PfRlh4lop
October 21st 2019, 11:10am
GantosJ @GantosJ
RT @StunningFeline: $PSTI treatment for CLI is a game changer. Listen to the Dr talk about how she could hear a pulse prior to treatment an…
October 21st 2019, 10:10am
GantosJ @GantosJ
RT @phatoftheland10: Say NO to amputation. #CLIFighters #StopCLI $psti #diabetes #DiabetesAwareness https://t.co/pWXNPdyd9g
October 21st 2019, 10:10am
phatoftheland10 @phatoftheland10
Say NO to amputation. #CLIFighters #StopCLI $psti #diabetes #DiabetesAwareness https://t.co/pWXNPdyd9g
October 21st 2019, 10:10am
GantosJ @GantosJ
@StunningFeline True, despite the fact that this $PSTI Ph3 trial is double blinded & placebo controlled... but as D… https://t.co/ZA4woZfotj
October 21st 2019, 9:10am
dakotafinancial @dakotafinancial
Pluristem Therapeutics $PSTI Rating Increased to Buy at Zacks Investment Research https://t.co/yZT8fy09Rz
October 21st 2019, 9:10am
GantosJ @GantosJ
@StunningFeline That's the best proof that $PSTI cell-therapy is the reason the #CLI patient grow new blood vessels… https://t.co/E0iBh3HpKg
October 21st 2019, 9:10am
StunningFeline @StunningFeline
$PSTI treatment for CLI is a game changer. Listen to the Dr talk about how she could hear a pulse prior to treatmen… https://t.co/wiZjN3FaTW
October 21st 2019, 9:10am
GantosJ @GantosJ
$PSTI PLX-PAD cells can grow more arteries to restore blood flow to his legs so the wounds on his toes would heal.… https://t.co/SDjN8WniMp
October 21st 2019, 8:10am
GantosJ @GantosJ
The $PSTI Cell-Therapy saved this #CLI 77 years old patient's leg from certain imputation as gangrene spread due… https://t.co/OEvBRT5Bq9
October 21st 2019, 8:10am
TheMarketsDaily @TheMarketsDaily
Pluristem Therapeutics $PSTI Upgraded to “Buy” at Zacks Investment Research https://t.co/euAkBSsYqd
October 19th 2019, 1:10pm
macondailynews @macondailynews
Zacks Investment Research Upgrades Pluristem Therapeutics $PSTI to “Buy” https://t.co/e9cqzXrM8o
October 19th 2019, 1:10pm
dakotafinancial @dakotafinancial
Pluristem Therapeutics $PSTI Stock Price Crosses Above 200-Day Moving Average of $2.05 https://t.co/xpf9Z30kjs
October 18th 2019, 5:10am
ZolmaxNews @ZolmaxNews
Pluristem Therapeutics $PSTI Raised to Buy at Zacks Investment Research https://t.co/xsMoq0t2hv
October 17th 2019, 10:10am
bbnsnews @bbnsnews
Pluristem Therapeutics $PSTI Stock Price Passes Above 200 Day Moving Average of $2.05 https://t.co/QSsP9ucL3C
October 16th 2019, 5:10pm
ConsumerFeed @ConsumerFeed
Pluristem Therapeutics $PSTI Shares Pass Above 200 Day Moving Average of $2.05 https://t.co/h2EePiptaX
October 16th 2019, 5:10pm
macondailynews @macondailynews
Pluristem Therapeutics Inc. $PSTI Expected to Announce Earnings of -$0.80 Per Share https://t.co/dZm6pz96gC
October 12th 2019, 5:10pm
dakotafinancial @dakotafinancial
Pluristem Therapeutics Inc. $PSTI Expected to Post Earnings of -$0.80 Per Share https://t.co/ADwpkPMU9H
October 9th 2019, 11:10pm
AmericanBanking @AmericanBanking
Pluristem Therapeutics Inc. $PSTI Expected to Post Earnings of -$0.80 Per Share https://t.co/qRvFyk3Vn0 #stocks
October 9th 2019, 11:10pm
GantosJ @GantosJ
$PSTI Pluristem Therapeutics Inc. Insiders Increased Their Holdings https://t.co/Cmfidl6p5f
October 9th 2019, 11:10am
stocknewstimes @stocknewstimes
Pluristem Therapeutics $PSTI Share Price Passes Above Two Hundred Day Moving Average of $1.90 https://t.co/xsx9yXP08K
October 7th 2019, 10:10pm
TranscriptDaily @TranscriptDaily
Pluristem Therapeutics $PSTI Shares Pass Above 200 Day Moving Average of $1.90 https://t.co/kBQcMyvvxj
October 7th 2019, 10:10pm
scriptstotrade @scriptstotrade
$PSTI $SES Do you have all the tools you need to start your week? Here is our REVERSE SPLIT scanner with earnings… https://t.co/Kkt2iWYEAl
September 30th 2019, 6:09pm
OlympiaReport @OlympiaReport
Pluristem Therapeutics Inc. $PSTI Short Interest Update https://t.co/BEQW69V4SR
September 29th 2019, 11:09pm
dispatchtribune @dispatchtribune
Pluristem Therapeutics Inc. $PSTI Short Interest Update https://t.co/tQNwM8dLGm
September 29th 2019, 11:09pm
TickerReport @TickerReport
Pluristem Therapeutics Inc. $PSTI Short Interest Up 9.0% in September https://t.co/Zn14Ags62s
September 28th 2019, 8:09am
ZolmaxNews @ZolmaxNews
Pluristem Therapeutics Inc. $PSTI Short Interest Up 9.0% in September https://t.co/nAEoTDMLZi
September 28th 2019, 8:09am
AmericanBanking @AmericanBanking
Pluristem Therapeutics Inc. $PSTI Short Interest Up 9.0% in September https://t.co/PxxfrGOvQM #stocks
September 28th 2019, 8:09am
WatchlistN @WatchlistN
Pluristem Therapeutics Inc. $PSTI Short Interest Up 9.0% in September https://t.co/vNrIVI2N6j
September 28th 2019, 8:09am
ThisLincolnian @ThisLincolnian
Pluristem Therapeutics $PSTI Stock Price Passes Above 200 Day Moving Average of $1.75 https://t.co/1cyKtVZSiQ
September 24th 2019, 7:09pm
WeekHerald @WeekHerald
Pluristem Therapeutics $PSTI Share Price Passes Above 200 Day Moving Average of $1.75 https://t.co/d8OLO68uu8
September 24th 2019, 7:09pm
scientwest @scientwest
RT @GantosJ: $PSTI have the cell-therapy to treat #PAD #CLI US study: 30% of black men and women were estimated to develop PAD during thei…
September 24th 2019, 10:09am
GantosJ @GantosJ
$PSTI have the cell-therapy to treat #PAD #CLI US study: 30% of black men and women were estimated to develop PAD… https://t.co/ut54c6I9oZ
September 24th 2019, 8:09am
TranscriptDaily @TranscriptDaily
Zacks: Analysts Expect Pluristem Therapeutics Inc. $PSTI to Post -$0.70 EPS https://t.co/eW2URRo5qn
September 22nd 2019, 10:09pm
stocknewstimes @stocknewstimes
Analysts Anticipate Pluristem Therapeutics Inc. $PSTI Will Post Earnings of -$0.70 Per Share https://t.co/qYzIIe3toR
September 22nd 2019, 10:09pm
SleekMoneycom @SleekMoneycom
Analysts Anticipate Pluristem Therapeutics Inc. $PSTI Will Post Earnings of -$0.70 Per Share https://t.co/ypWJkzc4NU #investing
September 22nd 2019, 10:09pm
storminvestor @storminvestor
Analysts Anticipate Pluristem Therapeutics Inc. $PSTI Will Post Earnings of -$0.70 Per Share https://t.co/PqneomTM1s #markets
September 22nd 2019, 10:09pm
GantosJ @GantosJ
@semodough Good $PSTI summary by Ladenburg analyst, but he's missing the point of the #CLI European submission post… https://t.co/PhWHlh8GUS
September 17th 2019, 2:09pm
semodough @semodough
$PSTI catalysts lead clinical program, PLX-PAD for muscle regeneration after hip fracture surgery is in Phase 3 dev… https://t.co/SE0Zpsoyan
September 17th 2019, 1:09pm
Gambiste1 @Gambiste1
RT @GantosJ: $PSTI Recaps KOL Call Hematological Programs Data from 1st & 2nd cohorts of hematological study showed PLX-R18 was safe & wel…
September 17th 2019, 9:09am
OpenOutcrier @OpenOutcrier
$PSTI (+3.9% pre) Pluristem Therapeutics Recaps Key Opinion Leader Call Reviewing Hematological Programs - SI https://t.co/D4BnZR2gsK
September 17th 2019, 8:09am
IncredibleTrade @IncredibleTrade
H.C. Wainwright analyst Swayampakula Ramakanth raised the price target on Pluristem Therapeutics (NASDAQ: $PSTI) to… https://t.co/VsZLCI2SW1
September 17th 2019, 7:09am
IncredibleTrade @IncredibleTrade
Ladenburg Thalmann analyst Matthew Kaplan raised the price target on Pluristem Therapeutics (NASDAQ: $PSTI) to $25.… https://t.co/R9IJnzKPvl
September 17th 2019, 6:09am
AmericanBanking @AmericanBanking
Brokerages Expect Pluristem Therapeutics Inc. $PSTI to Announce -$0.70 EPS https://t.co/bVDXIuU0Pl #stocks
September 17th 2019, 4:09am
LifeSciAdvisors @LifeSciAdvisors
Pluristem Therapeutics $PSTI Recaps Key Opinion Leader Call Reviewing Hematological Programs https://t.co/wIsIAJECSW
September 16th 2019, 6:09pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.